围标串标

Search documents
平顶山市联合调查组致歉
券商中国· 2025-07-17 03:56
Core Viewpoint - The investigation into the "Niulang and Zhinu" sculpture project in Lushan County revealed significant issues in decision-making and oversight, leading to the dismissal of key officials and legal actions against those involved [1][2][3]. Group 1: Investigation Findings - The Lushan County government was found to have made decisions regarding the sculpture project without proper procedures and oversight, resulting in criticism and mandated self-reflection from the main responsible officials [2][3]. - The project was executed with irregularities such as "build first, bid later," collusion in bidding, and inflated costs, with a recalculated cost of approximately 2.07 million yuan instead of the reported 7.15 million yuan [1][3]. Group 2: Consequences and Actions Taken - Key officials, including the head of the Lushan County Housing and Urban-Rural Development Bureau, were dismissed due to their roles in the project, and one official was sentenced to three years in prison with a three-year probation for corruption [1][3]. - The company involved in the bidding irregularities, Ruize Art (Shenzhen) Co., Ltd., faced fines and legal penalties, with its representatives receiving prison sentences and fines for their involvement in the collusion [3].
围标串标!国药控股旗下两家公司被武警部队暂停采购资格
Qi Lu Wan Bao· 2025-06-24 02:46
Group 1 - The core point of the news is the suspension of procurement activities for two subsidiaries of China National Pharmaceutical Group Corporation (Sinopharm) due to violations of procurement regulations [1][7][9] - The companies involved are Sinopharm (Tianjin) Dongfang Bokang Pharmaceutical Co., Ltd. and Sinopharm Medical Technology (Tianjin) Co., Ltd., both of which are accused of engaging in fraudulent bidding practices [1][7] - The suspension will take effect from June 20, 2025, and will prevent the companies and their associated representatives from participating in military procurement activities during the suspension period [2][9] Group 2 - Sinopharm (Tianjin) Dongfang Bokang Pharmaceutical Co., Ltd. was established on January 6, 1994, and its current legal representative is Liu Zhanwen [13][14] - Sinopharm Medical Technology (Tianjin) Co., Ltd. was established on February 22, 2012, and its current legal representative is Kuang Yu [18] - The legal representatives and major shareholders of both companies are prohibited from participating in military procurement activities during the suspension [2][9]